In 2004, Nyström and colleagues showed for the first time via a flow-mediated dilation (FMD) technique, that GLP-1 infusion ameliorates endothelial dysfunction in T2DM patients with established coronary artery disease [122]. This evidence concerns the gene GCG and type 2 diabetes mellitus.